Paragraph 2 I1

disease to humans including allergenic or toxic effects;

disease to animals or plants;

adverse effects resulting from the inability to treat disease or offer an effective prophylaxis;

adverse effects resulting from establishment or dissemination of the genetically modified micro-organisms in the environment;

adverse effects resulting from the natural transfer of genetic material to or from other organisms;

adverse effects resulting from the likely interaction of the genetically modified micro-organism with other organisms at the premises where the contained use is to be conducted.